血代謝物による尿石病リスクに対する食事の影響:遺伝子,代謝物,および臨床的結果を結びつけるメンデルのランダム化と実験的研究
Dawei Wang1, Donghui Shi2, Shuxin Si3
1Department of Urology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.
Food science & nutrition
|August 22, 2025
まとめ
この研究では,食習慣が尿細症のリスクに影響し,この効果を媒介するプラズマ代謝産物があることが明らかになりました. これらのリンクを特定することで 腎臓石の予防策を策定できます
科学分野:
- 遺伝学と代謝学
- 栄養学的流行病学
- 泌尿器科
背景:
- ウロリチアシスは,健康に重大な影響を及ぼす一般的な再発性疾患です.
- ダイエット,血代謝産物,尿石病のリスクとの正確な因果関係は十分に理解されていません.
研究 の 目的:
- 食習慣と尿路石病のリスクとの因果関係を調査する.
- メンデルのランダム化 (MR) と実験的方法を用いて,この関係における血代謝物の媒介的役割を定量化する.
主な方法:
- ヨーロッパの祖先からの全ゲノム関連研究 (GWAS) のデータを用いて2つのサンプルメンデルのランダム化 (MR) を採用した (10,556例,400,681対照).
- 2段階のMRIを用いて,食習慣によるメタボリテッドによる尿石病の影響を評価した.
- カルシウムオキシラート (CaOx) 腎石のラットモデルと遺伝子発現分析 (RNA-Seq,RT-qPCR) による標的代謝結果の検証.
主要な成果:
- 尿路石腫の危険に関連した8つの食物の摂取要因と15の食物の好み要因を特定した.
- 尿細症に関連した50の血代謝物質が発見され,7つの食物代謝物質のペアが特定されました.
- マノースとスレオネート濃度の低下がCaOx腎石モデルで観察され,LAMA2とCSNK1G3遺伝子のダウンレギュレーションがCaOx腎石リスクの低下と関連していることが確認された.
結論:
- 血代謝物によって媒介される食習慣と尿石病のリスクとの因果関係が確立された.
- 発見は,食事介入による尿石病の予防と管理のための潜在的な標的を強調しています.
- 特定代謝産物および遺伝子 (LAMA2,CSNK1G3) を腎石疾患の潜在的なバイオマーカーまたは治療標的として特定した.
関連する概念動画
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
31
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
31
01:30Urinary Tract Calculi III: Medical Management
23
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
23
01:28Urinary Tract Calculi I: Introduction
42
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
42
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
40
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
40
01:28Urinary Tract Calculi V: Nursing Management
28
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
28
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
315
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
315